Allergy Therapeutics
AGY.L
#7060
Rank
โ‚ฌ0.36 B
Marketcap
0,07592ย โ‚ฌ
Share price
3.20%
Change (1 day)
105.69%
Change (1 year)

Revenue for Allergy Therapeutics (AGY.L)

Revenue in 2024: โ‚ฌ63.7 Million

According to Allergy Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ63.7 Million. In 2024 the company made a revenue of โ‚ฌ63.7 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ68.56 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Allergy Therapeutics from 2002 to 2024

Annual revenue

Year Revenue Change
2024โ‚ฌ63.7 M-7.09%
2023โ‚ฌ68.56 M-14.85%
2022โ‚ฌ80.52 M-24.38%
2021โ‚ฌ0.10 B21.26%
2020โ‚ฌ87.82 M2.87%
2019โ‚ฌ85.36 M3.66%
2018โ‚ฌ82.35 M8.18%
2017โ‚ฌ76.12 M27.75%
2016โ‚ฌ59.58 M-3.95%
2015โ‚ฌ62.03 M-4.84%
2014โ‚ฌ65.19 M19.6%
2013โ‚ฌ54.5 M-7.74%
2012โ‚ฌ59.07 M-3.05%
2011โ‚ฌ60.93 M9.69%
2010โ‚ฌ55.55 M-2.05%
2009โ‚ฌ56.71 M0.56%
2008โ‚ฌ56.39 M19.97%
2007โ‚ฌ47.01 M18.31%
2006โ‚ฌ39.73 M18.08%
2005โ‚ฌ33.65 M12.59%
2004โ‚ฌ29.88 M14.69%
2003โ‚ฌ26.06 M23.14%
2002โ‚ฌ21.16 M